Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.

Clinical trial NCT06640166 · RECRUITING

Trial details

NCT number: NCT06640166
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Carcinoma Colorectal Neoplasms Colorectal Tumor Colorectal Adenocarcinoma Colorectal Cancer (CRC)Colorectal Cancer Colon Cancer Colon Adenocarcinoma Colon Carcinoma Colon Neoplasm

Start date: 2024-06-03
Primary completion: 2025-12-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.